AIDS 2026: Gilead, governments must make HIV prevention medicine more accessible
|
Lenacapavir can prevent HIV, but only if people can
access it. Lenacapavir is an injectable version of pre-exposure prophylaxis
(PrEP) that only needs ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...